Literature DB >> 11311775

Nitroimidazole-resistant vaginal trichomoniasis treated with paromomycin.

W A Poppe1.   

Abstract

A 33-year old woman with nitroimidazole-resistant vaginal trichomoniasis is described. She was treated with intravaginal paromomycin (500 mg daily for 2 days). This cured the trichomoniasis but resulted in severe local side effects. Paromomycin may be useful for difficult cases of nitroimidazole-resistant Trichomonas vaginalis vaginitis. The exact dosage still has to be determined.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11311775     DOI： 10.1016/s0301-2115(00)00403-6

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN： 0301-2115            Impact factor:   2.435


  5 in total

Review 1.  Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.

Authors:  Vahab Ali; Tomoyoshi Nozaki
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

Review 2.  Overview of computational vaccinology: vaccine development through information technology.

Authors:  Nishita Vaishnav; Aparna Gupta; Sneha Paul; Georrge J John
Journal:  J Appl Genet       Date:  2014-12-23       Impact factor: 3.240

Review 3.  Management of Resistant Trichomoniasis.

Authors:  Cynthia Alessio; Paul Nyirjesy
Journal:  Curr Infect Dis Rep       Date:  2019-08-06       Impact factor: 3.725

Review 4.  Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.

Authors:  Sarah L Cudmore; Kiera L Delgaty; Shannon F Hayward-McClelland; Dino P Petrin; Gary E Garber
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  Refractory Trichomoniasis in HIV-positive and HIV-negative Subjects.

Authors:  Megan R Miller; Paul Nyirjesy
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.663
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.